中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
27期
22-23
,共2页
依达拉奉%奥扎格雷钠%急性脑梗死
依達拉奉%奧扎格雷鈉%急性腦梗死
의체랍봉%오찰격뢰납%급성뇌경사
Edaravone%Ozagrel sodium%Acute cerebral infarction
目的:进一步研究和比较临床治疗急性脑梗死实践过程中采用依达拉奉联合奥扎格雷钠治疗方法的实际治疗效果,从而为临床实践提供指导和依据。方法:以本院2010年12月-2012年12月收治的急性脑梗死患者92例为研究对象进行了回顾性分析。结果:实施治疗前,两组患者的NIHSS评分和ADL指数评分结果比较差异无统计学意义;实施治疗后14 d和30 d,联合用药组患者的NIHSS评分和ADL指数评分结果显著地低于单纯用药组患者水平,比较差异具有统计学意义(P<0.05)。结论:在临床针对急性脑梗死患者实施治疗的过程中采用依达拉奉联合奥扎格雷钠治疗方法的临床治疗效果显著,是临床治疗急性脑梗死患者的安全可靠选择。
目的:進一步研究和比較臨床治療急性腦梗死實踐過程中採用依達拉奉聯閤奧扎格雷鈉治療方法的實際治療效果,從而為臨床實踐提供指導和依據。方法:以本院2010年12月-2012年12月收治的急性腦梗死患者92例為研究對象進行瞭迴顧性分析。結果:實施治療前,兩組患者的NIHSS評分和ADL指數評分結果比較差異無統計學意義;實施治療後14 d和30 d,聯閤用藥組患者的NIHSS評分和ADL指數評分結果顯著地低于單純用藥組患者水平,比較差異具有統計學意義(P<0.05)。結論:在臨床針對急性腦梗死患者實施治療的過程中採用依達拉奉聯閤奧扎格雷鈉治療方法的臨床治療效果顯著,是臨床治療急性腦梗死患者的安全可靠選擇。
목적:진일보연구화비교림상치료급성뇌경사실천과정중채용의체랍봉연합오찰격뢰납치료방법적실제치료효과,종이위림상실천제공지도화의거。방법:이본원2010년12월-2012년12월수치적급성뇌경사환자92례위연구대상진행료회고성분석。결과:실시치료전,량조환자적NIHSS평분화ADL지수평분결과비교차이무통계학의의;실시치료후14 d화30 d,연합용약조환자적NIHSS평분화ADL지수평분결과현저지저우단순용약조환자수평,비교차이구유통계학의의(P<0.05)。결론:재림상침대급성뇌경사환자실시치료적과정중채용의체랍봉연합오찰격뢰납치료방법적림상치료효과현저,시림상치료급성뇌경사환자적안전가고선택。
Objective:To further study and compare the clinical treatment of edaravone combined with ozagrel in the treatment of acute cerebral infarction,so as to provide guidance and basis for clinical practice. Method:92 patients with acute cerebral infarction in our hospital from December 2010 to December 2012 were chosen as the research object. And they were taken for retrospectively analysis. Result:In the comparison of NIHSS score and ADL index score,implementation before treatment,compared between groups,the score of NIHSS scale and ADL index in the patients of the two groups had no difference,there was no significant difference. 14 days and 30 days after the implementation,compared between groups,the scores of NIHSS scale and ADL index in the combination group were significantly lower than the that in patients with simple drug group,the difference was statistically significant (P<0.05). Conclusion:The clinical treatment effect of edaravone combined with sodium ozagrel in the treatment of patients with acute cerebral infarction is remarkable,and it is a safe and reliable choice for the clinical treatment of patients with acute cerebral infarction.